FBXL3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.366170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.110600E-01
Normal-vs-Stage2
1.438780E-01
Normal-vs-Stage3
1.728420E-02
Normal-vs-Stage4
3.544000E-01
Stage1-vs-Stage2
2.667600E-01
Stage1-vs-Stage3
2.529800E-02
Stage1-vs-Stage4
7.932000E-01
Stage2-vs-Stage3
1.637980E-01
Stage2-vs-Stage4
5.022200E-01
Stage3-vs-Stage4
1.453710E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.022990E-01
Normal-vs-AfricanAmerican
6.803400E-01
Normal-vs-Asian
1.253160E-01
Caucasian-vs-AfricanAmerican
1.587800E-01
Caucasian-vs-Asian
3.565200E-01
AfricanAmerican-vs-Asian
1.780170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.223200E-01
Normal-vs-Female
1.732150E-01
Male-vs-Female
4.020000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.165000E-01
Normal-vs-Age(41-60Yrs)
3.386800E-01
Normal-vs-Age(61-80Yrs)
9.544400E-02
Normal-vs-Age(81-100Yrs)
2.022400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.830400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.628000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.668400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.289960E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.967600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.995200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.030400E-02
Normal-vs-Daily Drinker
3.385700E-02
Normal-vs-Weekly Drinker
7.440300E-02
Normal-vs-Occasional Drinker
2.518400E-01
Normal-vs-Social Drinker
3.049800E-01
Non Drinker-vs-Daily Drinker
8.751200E-01
Non Drinker-vs-Weekly Drinker
9.043000E-01
Non Drinker-vs-Occasional Drinker
1.831580E-01
Non Drinker-vs-Social Drinker
3.830400E-01
Daily Drinker-vs-Weekly Drinker
9.928600E-01
Daily Drinker-vs-Occasional Drinker
1.320830E-01
Daily Drinker-vs-Social Drinker
3.197400E-01
Weekly Drinker-vs-Occasional Drinker
2.156400E-01
Weekly Drinker-vs-Social Drinker
4.185400E-01
Occasional Drinker-vs-Social Drinker
8.062800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.389780E-01
Normal-vs-Grade 2
2.558000E-02
Normal-vs-Grade 3
4.325900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.403200E-01
Grade 1-vs-Grade 3
9.566600E-01
Grade 1-vs-Grade 4
1.389780E-01
Grade 2-vs-Grade 3
4.284200E-01
Grade 2-vs-Grade 4
2.558000E-02
Grade 3-vs-Grade 4
4.325900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.609600E-02
Normal-vs-NonDiabetic
9.196400E-02
Diabetic-vs-NonDiabetic
6.687200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.924010E-02
Normal-vs-NoPancreatitis
1.180850E-01
Pancreatitis-vs-NoPancreatitis
1.765180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.459580E-01
Normal-vs-N1
1.503380E-01
N0-vs-N1
5.562400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.374180E-01
Normal-vs-TP53-NonMutant
3.756400E-01
TP53-Mutant-vs-TP53-NonMutant
2.908800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
